Loading...

Skip to main content

Call us on + 1 (800) 604-9114 for more information about our products

Looking for specific datasheet Manual/COA/MSDS?
Request a Manual/COA/MSDS

Interested to get a quote about our products?
Request a Quote

Immunohistochemistry (IHC) (Figure 1 Immunohistochemistry Validation of SARS-CoV-2 (COVID-19) Spike in COVID-19 Patient LungImmunohistochemical analysis of paraffin-embedded COVID-19 patient lung tissue using anti-SARS-CoV-2 (COVID-19) Spike S2 antibody (PM-9428, 0.5ug/mL). Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4 degree. A goat anti-mouse IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin. Strong spike protein signal was observed in macrophages of COVID-19 patient lung, but not in non-COVID-19 patient lung.)

Mouse COVID 19 Spike S2 Coronavirus Monoclonal Antibody | anti-COVID-19 antibody

SARS-CoV-2 (COVID-19) Spike S2 Antibody [4F10]

Reactivity
Virus
Predicted reactivity based on immunogen sequence: SARS-CoV Spike proteins: (100%)
Applications
ELISA, Western Blot, Immunohistochemistry, Immunofluorescence
Purity
SARS-CoV-2 (COVID-19) Spike Antibody is affinity chromatography purified via peptide column.
Synonyms
COVID 19 Spike S2 Coronavirus; Monoclonal Antibody; SARS-CoV-2 (COVID-19) Spike S2 Antibody [4F10]; 2019 Novel Coronavirus; Coronavirus; CoV; COVID-19 virus; HCoV-2; Human Coronavirus 2019; SARS2; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Spike S2SARS-CoV-2 (COVID-19) Spike S2 Antibody: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Surface Glycoprotein; Spike protein; anti-COVID-19 antibody
Ordering
For Research Use Only!
Host
Mouse
Reactivity
Virus
Predicted reactivity based on immunogen sequence: SARS-CoV Spike proteins: (100%)
Clonality
Monoclonal
Isotype
IgG1
Clone Number
4F10
Purity/Purification
SARS-CoV-2 (COVID-19) Spike Antibody is affinity chromatography purified via peptide column.
Form/Format
Liquid; SARS-CoV-2 (COVID-19) Spike Antibody is supplied in PBS containing 0.02% sodium azide.
Concentration
1mg/mL (varies by lot)
Applicable Applications for anti-COVID-19 antibody
ELISA (EIA), Western Blot (WB), Immunohistochemistry-Paraffin (IHC-P), Immunofluorescence (IF)
Application Notes
WB: 1ug/mL
IF: 20ug/mL
IHC: 0.5ug/mL

Antibody validated: Immunofluorescence and Western blot in human samples. Immunohisochemistry in COVID-19 patient samples. SARS-CoV-2 (COVID-19) Spike S2 antibody can be used for the detection of SARS-CoV-2 (COVID-19) Spike full length protein in ELISA. It will detect 4 ng of free peptide at 1ug/mL. The antibody cannot be used for detection of SARS-CoV-2/SARS-CoV Spike S1, Spike ECD, Spike S2 ECD proteins. ) All other applications and species not yet tested.
Immunogen
Anti-SARS-CoV-2 (COVID-19) Spike S2 antibody was raised against a peptide corresponding to 20 amino acids near the carboxy terminus of SARS-CoV-2 (COVID-19) Spike glycoprotein.

The immunogen is located within the last 50 amino acids of SARS-CoV-2 (COVID-19) Spike protein.
Conjugation
Unconjugated
Protein GI#
1791269090
Isoform
SARS-CoV-2 (COVID-19) Spike has one isoform (1273aa).
NCBI Organism
Wuhan seafood market pneumonia virus
Preparation and Storage
SARS-CoV-2 (COVID-19) Spike S2 antibody can be stored at 4 degree C for three months and -20 degree C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Immunohistochemistry (IHC)

(Figure 1 Immunohistochemistry Validation of SARS-CoV-2 (COVID-19) Spike in COVID-19 Patient LungImmunohistochemical analysis of paraffin-embedded COVID-19 patient lung tissue using anti-SARS-CoV-2 (COVID-19) Spike S2 antibody (PM-9428, 0.5ug/mL). Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4 degree. A goat anti-mouse IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin. Strong spike protein signal was observed in macrophages of COVID-19 patient lung, but not in non-COVID-19 patient lung.)

Immunohistochemistry (IHC) (Figure 1 Immunohistochemistry Validation of SARS-CoV-2 (COVID-19) Spike in COVID-19 Patient LungImmunohistochemical analysis of paraffin-embedded COVID-19 patient lung tissue using anti-SARS-CoV-2 (COVID-19) Spike S2 antibody (PM-9428, 0.5ug/mL). Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4 degree. A goat anti-mouse IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin. Strong spike protein signal was observed in macrophages of COVID-19 patient lung, but not in non-COVID-19 patient lung.)

Western Blot (WB)

(Figure 2 Overexpression Validation in Spike Transfected 293 Cells Loading: 5ug per lane of 293 cell lysate. Antibodies: SARS-CoV-2 (COVID-19) Spike S2, 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10,000 dilution.Lane 1: 0.5ug/mL and Lane 2: 1ug/mL)

Western Blot (WB) (Figure 2 Overexpression Validation in Spike Transfected 293 Cells Loading: 5ug per lane of 293 cell lysate. Antibodies: SARS-CoV-2 (COVID-19) Spike S2, 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10,000 dilution.Lane 1: 0.5ug/mL and Lane 2: 1ug/mL)

Immunofluorescence (IF)

(Figure 3 Immunofluorescence Validation of SARS-CoV-2 (COVID-19) Spike in 293T CellsImmunofluorescent analysis of 4% paraformaldehyde-fixed 293T cells labeling SARS-CoV-2 (COVID-19) Spike S2 with at 20ug/mL, followed by goat anti-mouse IgG secondary antibody at 1/500 dilution (red) and DAPI staining (blue).)

Immunofluorescence (IF) (Figure 3 Immunofluorescence Validation of SARS-CoV-2 (COVID-19) Spike in 293T CellsImmunofluorescent analysis of 4% paraformaldehyde-fixed 293T cells labeling SARS-CoV-2 (COVID-19) Spike S2 with at 20ug/mL, followed by goat anti-mouse IgG secondary antibody at 1/500 dilution (red) and DAPI staining (blue).)

ELISA (EIA)

(Figure 4 ELISA TestAntibodies: SARS-CoV-2 (COVID-19) Spike S2 antibody, (1ug/mL). A direct ELISA was performed using immunogen or control peptide as coating antigen and the anti-SARS-CoV-2 (COVID-19) Spike antibody as the capture antibody. Secondary: Goat anti-mouse IgG HRP conjugate at 1:5,000 dilution. Detection range is from 0.3 ng/mL to 1,000 ng/mL.)

ELISA (EIA) (Figure 4 ELISA TestAntibodies: SARS-CoV-2 (COVID-19) Spike S2 antibody, (1ug/mL). A direct ELISA was performed using immunogen or control peptide as coating antigen and the anti-SARS-CoV-2 (COVID-19) Spike antibody as the capture antibody. Secondary: Goat anti-mouse IgG HRP conjugate at 1:5,000 dilution. Detection range is from 0.3 ng/mL to 1,000 ng/mL.)
Related Product Information for anti-COVID-19 antibody
Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019-20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6).
Product Categories/Family for anti-COVID-19 antibody
References
Gorbalenya. bioRxiv: 2020.
Hui et al. Int J Infect Dis. 2020;91:264-266.
Belouzard et al. Viruses. 2012;4(6):1011-33.
Lee et al. J Virol. 2006;80(8):4079-87.
Wan et al. J Virol. 2020.
Wrapp et al. Science. 2020.

NCBI and Uniprot Product Information

NCBI GeneID
NCBI Official Full Name
Spike glycoprotein

Research Articles on COVID-19

Similar Products

Product Notes

The COVID-19 (Catalog #AAA154816) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The SARS-CoV-2 (COVID-19) Spike S2 Antibody [4F10] reacts with Virus Predicted reactivity based on immunogen sequence: SARS-CoV Spike proteins: (100%) and may cross-react with other species as described in the data sheet. AAA Biotech's COVID 19 Spike S2 Coronavirus can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Western Blot (WB), Immunohistochemistry-Paraffin (IHC-P), Immunofluorescence (IF). WB: 1ug/mL IF: 20ug/mL IHC: 0.5ug/mL Antibody validated: Immunofluorescence and Western blot in human samples. Immunohisochemistry in COVID-19 patient samples. SARS-CoV-2 (COVID-19) Spike S2 antibody can be used for the detection of SARS-CoV-2 (COVID-19) Spike full length protein in ELISA. It will detect 4 ng of free peptide at 1ug/mL. The antibody cannot be used for detection of SARS-CoV-2/SARS-CoV Spike S1, Spike ECD, Spike S2 ECD proteins.) All other applications and species not yet tested. Researchers should empirically determine the suitability of the COVID-19 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. It is sometimes possible for the material contained within the vial of "COVID 19 Spike S2 Coronavirus, Monoclonal Antibody" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.

Precautions

All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.

Disclaimer

Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.

Item has been added to Shopping Cart

If you are ready to order, navigate to Shopping Cart and get ready to checkout.

Looking for a specific manual?
Request a Manual

Request more Information

Please complete the form below and a representative will contact you as soon as possible.

Request a Manual

Please complete the form below and a representative will contact you as soon as possible.

Request a Quote

Please complete the form below and a representative will contact you as soon as possible.